Loading company…
Quantdetect develops sensitive diagnostics to measure tumor-derived DNA in cancer patients' blood.
Founded in 2021 and based in Tokyo, Japan, Quantdetect develops diagnostic tools to quantify tumor-derived DNA in the blood of cancer patients.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in